The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
On Dec. 1, 2006, the U.S. Centers for Disease Control and Prevention’s (CDC) advisory Committee on Immunization Practices…
On Nov. 27, 2006, the Animal Enterprise Terrorism Act (AETA) was officially signed into law. The legislation, which…
On Oct. 19, 2006, the FDA approved the drug, Gleevec developed by OHSU Cancer Institute researcher Brian Druker,…
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
On Oct 2, 2006, National Cancer Institute researchers have linked specific genetic mutations to defects in cells that…
On Sept. 28, 2006, the Virginia Bioinformatics Institute opened its new office complex in the National Capital Region,…
On Sept. 27, 2006, the National Cancer Institute announced funding for a major component of its $104 million,…
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
On Sept. 18, 2006, Integrated DNA Technologies (IDT) announced the acquisition of RNA-TEC, based in Leuven, Belgium. The…
On Sept. 15, 2006, John E. Niederhuber became the thirteenth director of the National Cancer Institute.
On Sept. 8, 2006, BD (Becton, Dickinson) announced an agreement to acquire the 93.5% of the outstanding shares…
On Sept. 6, 2006, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
On Sept. 1, 2006, National Cancer Institute researchers developed a new model for estimating the 5-year risk of…
On Aug. 23, 2006, the Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated. Designed as a national…
On Aug. 14, 2006, National Cancer Institute (NCI) researchers announced they had found a unique pattern of activity…
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
On Aug. 1, 2006, the Frances Langford Heart Center opened its doors bringing open-heart surgery and interventional cardiology…
On Jul. 21, 2006, Sandia and the University of New Mexico reported that experiments involving single-cell organisms in…
On Jul. 18, 20006, the Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement…
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved for use in the treatment of women…
On Jun. 30, 2006, Genentech drug Lucentisï¾™ (ranibizumab injection) was approved by the FDA for the treatment of…
On Jun. 29, 2006, the Immunization Practices Advisory Committee (ACIP) recommends second dose of varicella vaccine for children.
On Jun. 29, 2006, researchers at the National Cancer Institute have identified a link between inherited and acquired…
On Jun. 27, 2006, the U.S. Surgeon General released a report on the harmful health consequences of involuntary…
On Jun. 8, 2006, the FDA approved the vaccine Gardasil, which protects against persistent infection by the two…